Posttraumatic headache is a distinct headache type from migraine.

Journal

Current opinion in neurology

ISSN: 1473-6551

Titre abrégé: Curr Opin Neurol

Pays: England

ID NLM: 9319162

Informations de publication

Date de publication:
01 Feb 2024

Historique:

medline: 31 1 2024

pubmed: 31 1 2024

entrez: 31 1 2024

Statut: aheadofprint

Résumé

Posttraumatic headache (PTH), a headache that develops within 7 days of a causative injury, is one of the most common secondary headaches, mostly attributed to mild traumatic brain injury (mTBI). Because presence of preinjury headache is a risk factor for developing PTH and PTH symptoms often resemble migraine or tension-type headache, the association between PTH and primary headaches has attracted attention from clinicians and scientists. Recent studies on epidemiological aspects, headache features, risk factors, imaging characteristics, and response to treatment, suggest overlapping features and distinct objective findings in PTH compared to migraine. We argue that PTH is distinct from migraine. Therefore, PTH epidemiology, pathophysiology, diagnosis, treatment, and prognosis should continue to be investigated separately from migraine.

Identifiants

DOI: 10.1097/WCO.0000000000001247 PMID: 38294020

pubmed: 38294020

doi: 10.1097/WCO.0000000000001247

pii: 00019052-990000000-00139

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Ashina H, Iljazi A, Al-Khazali HM, et al. Persistent posttraumatic headache attributed to mild traumatic brain injury: deep phenotyping and treatment patterns. Cephalalgia 2020; 40:554–564.

Ashina H, Dodick DW, Barber J, et al. Prevalence of and risk factors for posttraumatic headache in civilian patients after mild traumatic brain injury: a TRACK-TBI study. Mayo Clin Proc 2023; 98:1515–1526.

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.

Hoffman JM, Lucas S, Dikmen S, et al. Natural history of headache after traumatic brain injury. J Neurotrauma 2011; 28:1719–1725.

Leibovit-Reiben Z, Ishii R, Dodick DW, et al. The impact of premorbid headaches on headache features and long-term health outcomes following traumatic brain injury: Insights from the American Registry for Migraine Research. Headache 2022; 62:566–576.

Scott BR, Uomoto JM, Barry ES. Impact of pre-existing migraine and other co-morbid or co-occurring conditions on presentation and clinical course following deployment-related concussion. Headache 2020; 60:526–541.

Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 2022; 23:34.

Mavroudis I, Ciobica A, Luca AC, Balmus IM. Post-traumatic headache: a review of prevalence, clinical features, risk factors, and treatment strategies. J Clin Med 2023; 12:4233.

Ashina H, Porreca F, Anderson T, et al. Posttraumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol 2019; 15:607–617.

Schwedt TJ. Posttraumatic headache due to mild traumatic brain injury: current knowledge and future directions. Cephalalgia 2021; 41:464–471.

Lucas S, Hoffman JM, Bell KR, Dikmen S. A prospective study of prevalence and characterization of headache following mild traumatic brain injury. Cephalalgia 2014; 34:93–102.

Lucas S, Ahn AH. Posttraumatic headache: classification by symptom-based clinical profiles. Headache 2018; 58:873–882.

Stacey A, Lucas S, Dikmen S, et al. Natural history of headache five years after traumatic brain injury. J Neurotrauma 2017; 34:1558–1564.

Lieba-Samal D, Platzer P, Seidel S, et al. Characteristics of acute posttraumatic headache following mild head injury. Cephalalgia 2011; 31:1618–1626.

Kjeldgaard D, Forchhammer H, Teasdale T, Jensen RH. Chronic posttraumatic headache after mild head injury: a descriptive study. Cephalalgia 2014; 34:191–200.

Schwedt TJ, Peplinski J, Garcia-Filion P, Berisha V. Altered speech with migraine attacks: a prospective, longitudinal study of episodic migraine without aura. Cephalalgia 2019; 39:722–731.

Chong CD, Zhang J, Li J, et al. Altered speech patterns in subjects with posttraumatic headache due to mild traumatic brain injury. J Headache Pain 2021; 22:82.

Ashina H, Al-Khazali HM, Iljazi A, et al. Psychiatric and cognitive comorbidities of persistent posttraumatic headache attributed to mild traumatic brain injury. J Headache Pain 2021; 22:83.

Buse DC, Silberstein SD, Manack AN, et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol 2013; 260:1960–1969.

Pellegrino ABW, Davis-Martin RE, Houle TT, et al. Perceived triggers of primary headache disorders: a meta-analysis. Cephalalgia 2018; 38:1188–1198.

Iba C, Ohtani S, Lee MJ, et al. Migraine triggers in Asian countries: a narrative review. Front Neurol 2023; 14:1169795.

Bille B. A 40-year follow-up of school children with migraine. Cephalalgia 1997; 17:488–491. discussion 7.

Bigal ME, Lipton RB. The prognosis of migraine. Curr Opin Neurol 2008; 21:301–308.

McGeary DD, Resick PA, Penzien DB, et al. Reason to doubt the ICHD-3 7-day inclusion criterion for mild TBI-related posttraumatic headache: a nested cohort study. Cephalalgia 2020; 40:1155–1167.

Howard L, Dumkrieger G, Chong CD, et al. Symptoms of autonomic dysfunction among those with persistent posttraumatic headache attributed to mild traumatic brain injury: a comparison to migraine and healthy controls. Headache 2018; 58:1397–1407.

Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology 1992; 42:1225–1231.

Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg 2018; 130:1080–1097.

D’Onofrio F, Russo A, Conte F, et al. Posttraumatic headaches: an epidemiological overview. Neurol Sci 2014; 35: (Suppl 1): 203–206.

Victor TW, Hu X, Campbell JC, et al. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 2010; 30:1065–1072.

Andersen AM, Ashina H, Iljazi A, et al. Risk factors for the development of post-traumatic headache attributed to traumatic brain injury: a systematic review. Headache 2020; 60:1066–1075.

Yilmaz T, Roks G, de Koning M, et al. Risk factors and outcomes associated with posttraumatic headache after mild traumatic brain injury. Emerg Med J 2017; 34:800–805.

Cancelliere C, Boyle E, Cote P, et al. Development and validation of a model predicting posttraumatic headache six months after a motor vehicle collision in adults. Accid Anal Prev 2020; 142:105580.

Mao L, Dumkrieger G, Ku D, et al. Developing multivariable models for predicting headache improvement in patients with acute posttraumatic headache attributed to mild traumatic brain injury: a preliminary study. Headache 2023; 63:136–145.

Hougaard A, Gaist D, Garde E, et al. Lack of reproducibility of resting-state functional MRI findings in migraine with aura. Cephalalgia 2023; 43:3331024231212574.

Maleki N, Finkel A, Cai G, et al. Posttraumatic headache and mild traumatic brain injury: brain networks and connectivity. Curr Pain Headache Rep 2021; 25:20.

Ofoghi Z, Dewey D, Barlow KM. A systematic review of structural and functional imaging correlates of headache or pain after mild traumatic brain injury. J Neurotrauma 2020; 37:907–923.

Schwedt TJ, Chong CD, Peplinski J, et al. Persistent posttraumatic headache vs. migraine: an MRI study demonstrating differences in brain structure. J Headache Pain 2017; 18:87.

Dumkrieger G, Chong CD, Ross K, et al. Static and dynamic functional connectivity differences between migraine and persistent posttraumatic headache: a resting-state magnetic resonance imaging study. Cephalalgia 2019; 39:1366–1381.

Chong CD, Berisha V, Ross K, et al. Distinguishing persistent posttraumatic headache from migraine: classification based on clinical symptoms and brain structural MRI data. Cephalalgia 2021; 41:943–955.

Larsen EL, Ashina H, Iljazi A, et al. Acute and preventive pharmacological treatment of posttraumatic headache: a systematic review. J Headache Pain 2019; 20:98.

Erickson JC. Treatment outcomes of chronic posttraumatic headaches after mild head trauma in US soldiers: an observational study. Headache 2011; 51:932–944.

Chan S, Kurowski B, Byczkowski T, Timm N. Intravenous migraine therapy in children with posttraumatic headache in the ED. Am J Emerg Med 2015; 33:635–639.

Friedman BW, Babbush K, Irizarry E, et al. An exploratory study of IV metoclopramide+diphenhydramine for acute posttraumatic headache. Am J Emerg Med 2018; 36:285–289.

Dubrovsky AS, Friedman D, Kocilowicz H. Pediatric posttraumatic headaches and peripheral nerve blocks of the scalp: a case series and patient satisfaction survey. Headache 2014; 54:878–887.

Seeger TA, Orr S, Bodell L, et al. Occipital nerve blocks for pediatric posttraumatic headache: a case series. J Child Neurol 2015; 30:1142–1146.

Kuczynski A, Crawford S, Bodell L, et al. Characteristics of posttraumatic headaches in children following mild traumatic brain injury and their response to treatment: a prospective cohort. Dev Med Child Neurol 2013; 55:636–641.

Cushman DM, Borowski L, Hansen C, et al. Gabapentin and tricyclics in the treatment of post-concussive headache, a retrospective cohort study. Headache 2019; 59:371–382.

Zirovich MD, Pangarkar SS, Manh C, et al. Botulinum toxin type A for the treatment of posttraumatic headache: a randomized, placebo-controlled. Cross-over Study Mil Med 2021; 186:493–499.

McGeary DD, Resick PA, Penzien DB, et al. Cognitive behavioral therapy for veterans with comorbid posttraumatic headache and posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Neurol 2022; 79:746–757.

Mollica A, Greben R, Oriuwa C, et al. Neuromodulation treatments for mild traumatic brain injury and postconcussive symptoms. Curr Neurol Neurosci Rep 2022; 22:171–181.

Stilling J, Paxman E, Mercier L, et al. Treatment of persistent post-traumatic headache and post-concussion symptoms using repetitive transcranial magnetic stimulation: a pilot, double-blind, randomized controlled trial. J Neurotrauma 2020; 37:312–323.

Leung A, Metzger-Smith V, He Y, et al. Left dorsolateral prefrontal cortex rTMS in alleviating MTBI related headaches and depressive symptoms. Neuromodulation 2018; 21:390–401.

Leung A, Shukla S, Fallah A, et al. Repetitive transcranial magnetic stimulation in managing mild traumatic brain injury-related headaches. Neuromodulation 2016; 19:133–141.

Leung A, Fallah A, Shukla S, et al. rTMS in alleviating mild TBI related headaches—a case series. Pain Physician 2016; 19:E347–E354.

Pinchuk D, Pinchuk O, Sirbiladze K, Shugar O. Clinical effectiveness of primary and secondary headache treatment by transcranial direct current stimulation. Front Neurol 2013; 4:25.

Ashina H, Iljazi A, Al-Khazali HM, et al. Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent posttraumatic headache attributed to mild traumatic brain injury: an open-label study. J Headache Pain 2020; 21:62.

Lanteri-Minet M, Fabre R, Martin C, et al. One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study. J Headache Pain 2023; 24:152.

Ramon C, Cernuda-Morollon E, Pascual J. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol 2017; 30:281–286.

Cernuda-Morollon E, Larrosa D, Ramon C, et al. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 2013; 81:1191–1196.

Cernuda-Morollon E, Ramon C, Martinez-Camblor P, et al. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 2015; 156:820–824.

Ashina H, Al-Khazali HM, Iljazi A, et al. Low plasma levels of calcitonin gene-related peptide in persistent posttraumatic headache attributed to mild traumatic brain injury. Cephalalgia 2020; 40:1276–1282.

Lee MJ, Lee SY, Cho S, et al. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. J Headache Pain 2018; 19:53.

Ashina H, Iljazi A, Al-Khazali HM, et al. CGRP-induced migraine-like headache in persistent posttraumatic headache attributed to mild traumatic brain injury. J Headache Pain 2022; 23:135.

Al-Khazali HM, Christensen RH, Dodick DW, et al. Hypersensitivity to opening of ATP-sensitive potassium channels in posttraumatic headache. Cephalalgia 2023; 43:3331024231210930.

Al-Khazali HM, Christensen RH, Dodick DW, et al. Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial. Brain 2023; awad367 [Epub ahead of print].

Ashina H, Schytz HW, Ashina M. CGRP in human models of migraine. Handb Exp Pharmacol 2019; 255:109–120.

Howden CW, Logue C, Gavin K, et al. Haemodynamic effects of intravenous human calcitonin-gene-related peptide in man. Clin Sci (Lond) 1988; 74:413–418.

Al-Karagholi MA, Hansen JM, Guo S, et al. Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain 2019; 142:2644–2654.

Al-Karagholi MA, Ghanizada H, Nielsen CAW, et al. Opening of ATP sensitive potassium channels causes migraine attacks with aura. Brain 2021; 144:2322–2332.

Schytz HW, Birk S, Wienecke T, et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 2009; 132 (Pt 1):16–25.

Benemei S, Labastida-Ramirez A, Abramova E, et al. Persistent posttraumatic headache: a migrainous loop or not? The preclinical evidence. J Headache Pain 2020; 21:90.

Bree D, Levy D. Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: implications for mechanisms of posttraumatic headache. Cephalalgia 2018; 38:246–258.

Romero-Reyes M, Ye Y. Pearls and pitfalls in experimental in vivo models of headache: conscious behavioral research. Cephalalgia 2013; 33:566–576.

Navratilova E, Rau J, Oyarzo J, et al. CGRP-dependent and independent mechanisms of acute and persistent posttraumatic headache following mild traumatic brain injury in mice. Cephalalgia 2019; 39:1762–1775.

Wang Y, Tye AE, Zhao J, et al. Induction of calcitonin gene-related peptide expression in rats by cortical spreading depression. Cephalalgia 2019; 39:333–341.

Hartings JA, Bullock MR, Okonkwo DO, et al. Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study. Lancet Neurol 2011; 10:1058–1064.

Daiutolo BV, Tyburski A, Clark SW, Elliott MB. Trigeminal pain molecules, allodynia, and photosensitivity are pharmacologically and genetically modulated in a model of traumatic brain injury. J Neurotrauma 2016; 33:748–760.

Moye LS, Tipton AF, Dripps I, et al. Delta opioid receptor agonists are effective for multiple types of headache disorders. Neuropharmacology 2019; 148:77–86.

Zhang J, Czerpaniak K, Huang L, et al. Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders. Pain 2020; 161:1381–1398.

Detke HC, Goadsby PJ, Wang S, et al. Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology 2018; 91:e2211–e2221.

Tepper S, Ashina M, Reuter U, et al. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 2017; 16:425–434.

Silberstein SD, Dodick DW, Bigal ME, et al. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med 2017; 377:2113–2122.

Christensen J, MacPherson N, Li C, et al. Repeat mild traumatic brain injuries (RmTBI) modify nociception and disrupt orexinergic connectivity within the descending pain pathway. J Headache Pain 2023; 24:72.

Ogunlaja O, Karsan N, Goadsby P. Emerging drugs for the prevention of migraine. Expert Opin Emerg Drugs 2021; 26:271–280.

Chabi A, Zhang Y, Jackson S, et al. Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis. Cephalalgia 2015; 35:379–388.